A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-01-02
著者
-
Oswald Stefan
Department Of Clinical Pharmacology Of The Peter Holtz Research Center Of Pharmacology And Experimen
-
Cascorbi Ingolf
Department Of Pharmacology University Of Kiel
-
Scheuch Eberhard
Department Of Clinical Pharmacology Of The Peter Holtz Research Center Of Pharmacology And Experimen
-
Siegmund Werner
Department Of Clinical Pharmacology Of The Peter Holtz Research Center Of Pharmacology And Experimen
関連論文
- Quantitative determination of the macrolide antibiotic tulathromycin in plasma and broncho-alveolar cells of foals using tandem mass spectrometry
- A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1
- Quantitative determination of nystatin in human plasma using LC-MS after inhalative administration in healthy subjects